Stockreport

Turnstone Biologics to Participate in Upcoming Investor Conferences

Turnstone Biologics Corp.  (TSBX) 
PDF SAN DIEGO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing [Read more]